Copyright
©The Author(s) 2015.
World J Transplant. Sep 24, 2015; 5(3): 110-128
Published online Sep 24, 2015. doi: 10.5500/wjt.v5.i3.110
Published online Sep 24, 2015. doi: 10.5500/wjt.v5.i3.110
Table 1 Sex, age, level of injury distribution of patients with traumatic disease of spinal cord (main group)
No. of patients | 202 (1008 case histories) |
Age | From 19 to 51 yr |
Gender | Males - 156, females - 46 |
Years post injury | Less than 1 yr - 11 |
From 1 to 5 yr - 144 | |
Over 5 yr - 47 | |
Level of spinal cord injury | Cervical level - 93 |
Thoracic level - 98 | |
Lumbar level - 11 | |
Type of injury | Complete - 43 |
Incomplete - 159 | |
No. of transplantations | No less than 20 HSCs and HPs transplantations |
Average number of transplanted cells | 5.8 × 106 |
Table 2 Sex, age, level of injury distribution of patients with traumatic disease of spinal cord (control group)
No. of patients | 20 (62 case histories) |
Age | From 18 to 44 yr |
Gender | Males - 13, females - 7 |
Years post injury | < 1 yr - 6 |
From 1 to 5 yr - 10 | |
Over 5 yr - 4 | |
Level of spinal cord injury | Cervical level - 14 |
Thoracic level - 4 | |
Lumbar level - 2 | |
Type | Complete - 12 |
Incomplete - 8 |
Table 3 The characteristics and basic differences of the hematopoietic stem cells and hematopoietic precursors preparation from the preparation of hematopoietic stem cells used for bone marrow transplantation
Technique | G-CSF dose | Period of administration (d) | Stimulation regimen | Cell markers | Cryopreservant |
Administration of HSCs in blood | 10-20 μg/kg | 6-7 | 1 in 24 h | CD34+, CD45+ | 10%-20% DMSO |
HLA DR+, CD38+ | |||||
Gp130± | |||||
Administration of HSC and HPs in CSF | 5 μg/kg; double dose at day 4 | 5 | 2 in 24 h | CD34+, CD45- | 5%-10% DMSO + |
HLA DR±, CD38± | polyglucin | ||||
Gp130+ |
Table 4 Clinical symptoms of the complications and side effects in spinal cord injury patients
Symptoms | Stages of research | Control group patients | ||
1 stage | 2 stage | 3 stage | ||
Increased spasticity | 46% | 49.9% | 54.5% | 0 |
Fever | 15% | 19% | 18.8% | 0 |
Post-puncture headache | 11% | 14.9% | 12.2% | 14.9% |
High blood pressure | 10% | 8.1% | 14.5% | 0 |
Coordination disturbance | 2.3% | 1.3% | 0 | 0 |
Dizziness | 2% | 3.4% | 0 | 4.2% |
Sleepiness | 2.1% | 1.7% | 0 | 0 |
Emotional lability | 1.6% | 1.7% | 0 | 0 |
Disordered consciousness | 1.2% | 0.8% | 0.8% | 0 |
Meningism | 3.7% | 2.95% | 0.8% | 0 |
Low blood pressure | 1.68% | 2.95% | 5.9% | 0 |
General % of the patients with complications | 63.5% | 72.9% | 75% | 19.1% |
- Citation: Bryukhovetskiy AS, Bryukhovetskiy IS. Effectiveness of repeated transplantations of hematopoietic stem cells in spinal cord injury. World J Transplant 2015; 5(3): 110-128
- URL: https://www.wjgnet.com/2220-3230/full/v5/i3/110.htm
- DOI: https://dx.doi.org/10.5500/wjt.v5.i3.110